Funding for this research was provided by:
ZonMw (916.13.078 and 917.17.308, 016.116.358)
H2020 European Research Council (281156)
European Union, EUCLIDS (EC-GA no. 279185)
Text and Data Mining valid from 2019-12-01
Received: 2 September 2019
Accepted: 16 December 2019
First Online: 28 December 2019
Ethics approval and consent to participate
: Written informed consent was obtained from all patients or their legally authorized representatives. The MeninGene study was approved by the medical ethical committee of the Academic Medical Centre, Amsterdam, the Netherlands. Animal experiments were approved by the Institutional Animal Care and Use Committee of the Academic Medical Center Amsterdam.
: Not applicable.
: RBP, DW, and TWK are co-inventors of a patent describing potentiating anti-FH antibodies and uses thereof. All other authors declare that they have no competing interests.